The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SI · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CGNX | ABT | SYK | SI |
|---|---|---|---|---|
| Moat Score (0–100) | 68 (highest) | 68 (highest) | 68 (highest) | 67 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 33 | 44 | 95 (highest) | 70 |
| Pricing power | 99 | 94 | 100 (highest) | 100 (highest) |
| Returns on capital | 71 (highest) | 36 | 30 | — |
| Balance-sheet safety | 100 (highest) | 85 | 45 | 55 |
| Capital allocation | 35 | 79 (highest) | 69 | 44 |
| 583% above value if growth stopped today | 91% above value if growth stopped today (largest discount to value if growth stopped today) | No price data | No price data | |
| Market cap | $10.4B | $179.2B | Not reported | $421M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |